Award
National Cancer Institute 5R01CA260399-05
Ovarian Cancer Detection with Blood- and Imaging-Based Biomarkers
Recipient
Not specified
Award Amount
$738,514.00
Ceiling
$738,514.00
Awarded
May 07, 2026
Identifier
5R01CA260399-05
NIH grant awarded by the National Cancer Institute for a project on early detection of ovarian cancer using blood and imaging biomarkers.
Description
This is a NIH grant project focused on developing blood- and imaging-based biomarkers for early detection of ovarian cancer. The project involves biomarker validation, endoscopic imaging, and clinical strategy development. The project duration is from January 1, 2022, to December 31, 2026.